Outcomes of patients with metastatic castration-resistant prostate cancer according to somatic damage dna repair gene alterations

HIGHLIGHTS

• who: Zou00e9 Neviere and collaborators from the Department of Oncology, University Hospital of Caen, Caen, France have published the article: Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations, in the Journal: (JOURNAL) of 31/Dec/2018
• what: The aim of this study was to describe outcomes of mCRPC patients treated with taxanes and/or NHT according to their somatic DDR profile, determined with a large 65-gene panel.
• future: Future studies are needed to confirm these findings. Because this study presents several limitations such . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.